Christina Antza | Hypertension | Best Research Article Award

Posted on 10/03/202510/03/2025 by Pencis

Assist. Prof. Dr. Christina Antza | Hypertension | Best Research Article Award

Assist. Prof. Dr. Christina Antza, 3rd Department of Internal Medicine, Aristotle University of Thessaloniki, Greece

Assist. Prof. Dr. Christina Antza is a specialist in Internal Medicine and Hypertension at the 3rd Department of Internal Medicine, Aristotle University of Thessaloniki, Greece. She holds an M.D., a Ph.D. in blood pressure measurement methods, and an M.Sc. in Research Methodology. Dr. Antza has extensive experience in hypertension, metabolic syndrome, diabetes, and atherosclerosis. She has worked as a researcher, consultant, and medical educator in Greece and the UK. Recognized with multiple awards and fellowships, she actively contributes to international medical research and education, shaping advancements in cardiovascular and metabolic disease management.

AUTHOR PROFILE

Orcid Profile

🎓 EARLY ACADEMIC PURSUITS:

Dr. Christina Antza began her educational journey at the Fifth High-School of Drama (Junior High School) and Third High School of Drama (Senior High School). She then pursued her Medical Degree at Aristotle University of Thessaloniki, Greece (2007-2013), graduating with an impressive 8/10 grade.

Her passion for research and academia led her to further studies, including:

Ph.D. in Internal Medicine (2014-2019) – Focused on blood pressure measurement methods and their ability to predict early vascular aging. She earned a Grade A with Distinction under the supervision of Prof. V. Kotsis.
Master of Science in Research Methodology in Medicine and Health Science (2016-2018) – Achieved an outstanding 9/10 grade.
Research Fellowship (2019-2020) – Conducted clinical and research work in Diabetes Mellitus and Obesity at the University of Birmingham, UK.
Postdoctoral Research (2019-2022) – Specialized in Hypertension and Metabolic Syndrome at Aristotle University of Thessaloniki.
Internal Medicine Consultant Certification (2021) – Earned after passing rigorous written and oral examinations.

💼 PROFESSIONAL ENDEAVORS:

Dr. Antza has held various prestigious roles in internal medicine, focusing on hypertension, metabolic syndrome, and endocrinology:

Scientific Associate (2013-2014) – Engaged in research and clinical practice in hypertension at the 3rd Department of Internal Medicine, Aristotle University of Thessaloniki.
Medical Resident (2016-2021) – Trained at Papageorgiou General Hospital, Aristotle University of Thessaloniki.
Academic Fellowship in Hypertension & Metabolic Syndrome (2021-2022) – Focused on clinical practice, independent teaching, and research.
Internal Medicine Consultant (2021-2023) – Served at Papageorgiou General Hospital and Bioclinic, offering expertise in hypertension, diabetes, and emergency medicine.
Assistant Professor of Internal Medicine – Hypertension (2023-Present) – Currently educating future medical professionals and leading research at Aristotle University of Thessaloniki.

Additionally, she has participated as a Subinvestigator in Phase 2 & 3 Clinical Trials, contributing to advancements in hypertension and metabolic disorders.

📚 CONTRIBUTIONS AND RESEARCH FOCUS ON HYPERTENSION:

Dr. Antza has extensively researched hypertension, metabolic syndrome, diabetes, lipid disorders, and vascular aging. Her work has focused on:

Blood Pressure Measurement Techniques (Home, Ambulatory, and Clinical).
Atherosclerosis and Cardiovascular Risk.
Metabolic Syndrome and Obesity-Related Disorders.
Diabetes and Endocrine Disorders.

She has been actively involved in research collaborations with leading medical institutions, including Queen Elizabeth Hospital, Birmingham, UK, where she served as an Honorary Observer (2019-2022) in the Endocrinology Department.

🏆 IMPACT AND INFLUENCE:

Dr. Antza’s work has been recognized with numerous awards and fellowships:

Young Fellow of the European Atherosclerosis Society (2019-Present).
Young Fellow of the European Hypertension Society (2023-Present).
Recipient of multiple Investigator Grants & Travel Awards from the European Society of Hypertension (ESH) and European Atherosclerosis Society (EAS).
1st Place Oral Presentation Award – 8th Panhellenic Congress of the Hellenic Atherosclerosis Society (2019).
2nd Clinical Research Award – 9th Panhellenic Congress of the Hellenic Atherosclerosis Society (2020).
Young Investigator Fellowship Award – 89th EAS Virtual Congress (2021).

📖 ACADEMIC CITATIONS & SCHOLARSHIPS:

Dr. Antza’s research has been widely cited in medical literature, influencing clinical guidelines in hypertension and metabolic diseases. Her scholarly excellence has earned her:

Ph.D. Scholarship from the Hellenic Society of Atherosclerosis (2014-2015).
Postdoctoral Research Scholarship from the State Scholarship Foundation (2019-2021).
Award from the Medical Sciences Deanery for Ph.D. Research (2020).

🌍 LEGACY AND FUTURE CONTRIBUTIONS:

Dr. Christina Antza is poised to make significant future contributions in the diagnosis and management of hypertension, metabolic syndrome, and cardiovascular diseases. Her expertise in clinical research, education, and innovative treatment strategies will continue to shape internal medicine and patient care.

Her future goals include:
✔ Expanding research on hypertension-related complications and vascular aging.
✔ Leading international collaborations in cardiovascular and metabolic diseases.
✔ Mentoring the next generation of medical professionals and researchers.
✔ Contributing to global guidelines on hypertension and cardiovascular risk management.

Her dedication to patient care, research, and teaching makes her an influential figure in modern internal medicine and hypertension research.

🌟CONCLUSION :

Assist. Prof. Dr. Christina Antza is a dedicated clinician, researcher, and educator in the fields of hypertension, metabolic syndrome, and internal medicine. With a strong academic foundation, international research collaborations, and numerous accolades, she continues to advance medical knowledge and improve patient care. Her contributions to medical education and research have made a lasting impact, inspiring future generations of physicians. As she progresses in her career, Dr. Antza remains committed to innovation, scientific discovery, and excellence in healthcare, shaping the future of cardiovascular and metabolic disease management. Her work stands as a testament to dedication and expertise.

TOP NOTABLE PUBLICATIONS

Clinic, Ambulatory and Home Blood Pressure Monitoring for Metabolic Syndrome: Time to Change the Definition?

Journal: Medicina

Year: 2025

The Microbial Perspective: A Systematic Literature Review on Hypertension and Gut Microbiota

Journal: Nutrients

Year: 2024

The Effects of Olive Oil Consumption on Biochemical Parameters and Body Mass Index of People with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Journal: Nutrients

Year: 2024

Familial Hypercholesterolemia in the Elderly: An Analysis of Clinical Profile and Atherosclerotic Cardiovascular Disease Burden from the Hellas-FH Registry

Journal: Biomedicines

Year: 2024

The Modern Environment: The New Secondary Cause of Hypertension?

Journal: Medicina

Year: 2023

The Importance of Out-of-Office Blood Pressure Measurement, as Highlighted by the Correlation with Left Ventricular Hypertrophy in an Untreated Hypertensive Population

Journal: Medicina

Year: 2023

QIU SUN | Vascular disease | Best Researcher Award

Posted on 04/03/202504/03/2025 by Pencis

Mr. QIU SUN | Vascular disease | Best Researcher Award

Mr. QIU SUN, Heilongjiang University of Chinese Medicine, China

Mr. Qiu Sun is the Director of the Department, Chief Physician, Associate Professor, and a Ph.D. candidate at Heilongjiang University of Chinese Medicine, China. A recognized expert in Traditional Chinese Medicine (TCM), he is a National Academic Successor and policy advisor in TCM healthcare. He has led multiple research projects, published SCI-indexed papers, and contributed to national textbooks. With two invention patents and numerous awards, he plays a key role in TCM education, clinical practice, and policy-making. His work focuses on integrative medicine, vascular diseases, and external treatments, making a significant impact on TCM’s modernization and global recognition.

AUTHOR PROFILE

Scopus Profile

🎓 EARLY ACADEMIC PURSUITS:

Mr. Sun Qiu was born in June 1982 and pursued his medical education at Heilongjiang University of Chinese Medicine, graduating in June 2009. His academic journey in Traditional Chinese Medicine (TCM) was marked by dedication to both theoretical and clinical practice. Currently, he is a Ph.D. candidate, continuously expanding his expertise in integrative medicine while mentoring future medical professionals as a Master’s Supervisor.

🏥 PROFESSIONAL ENDEAVORS:

As the Director of the Department, Chief Physician, and Associate Professor, Sun Qiu plays a crucial role in shaping TCM medical practices. His extensive responsibilities include supervising medical teams, enhancing healthcare quality, and pioneering innovative treatment methodologies. His leadership has significantly contributed to policy development in TCM hospitals across Heilongjiang Province.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON VASCULAR DISEASE:

Mr. Sun Qiu has been actively involved in various high-impact research projects, including:

Principal Investigator for 1 provincial-level project, 3 department-level projects, and 2 university-level projects
Participant in a National Natural Science Foundation of China (NSFC) project
Published 2 SCI-indexed papers and over 20 other research papers
Editor, co-editor, or contributor to 8 published books, exceeding 700,000 words
Holds 2 invention patents, reflecting his innovative contributions to TCM

His research primarily focuses on integrated traditional Chinese and Western medicine surgery, vascular diseases, and external treatment techniques in TCM.

🌍 IMPACT AND INFLUENCE:

Mr. Sun Qiu’s influence extends beyond clinical practice into policy-making and education. His key roles include:

National Academic Successor of Key Clinical Specialties in TCM
Expert in the Traditional Chinese Medicine Policy Think Tank
National Expert for the Supervision of TCM Statistical Data Quality
Project Review Expert for Science and Technology Departments in Sichuan, Anhui, and Guangxi Provinces

His editorial contributions to the “14th Five-Year Plan” National Textbook showcase his commitment to shaping the future of TCM education.

📚 ACADEMIC CITES & JOURNAL CONTRIBUTIONS:

Mr. Sun Qiu is an esteemed peer reviewer for international and national journals, including:

Scientific Reports (UK)
BMC Gastroenterology
Clinical Epigenetics
Chinese Health Preservation
China Contemporary Medicine

His role as a reviewer ensures high-quality research in TCM and integrative medicine.

🏆 LEGACY AND FUTURE CONTRIBUTIONS:

Mr. Sun Qiu has received numerous prestigious awards, including:

Second Prize from the Heilongjiang Provincial Government
First Prize from the Heilongjiang Administration of Traditional Chinese Medicine
Advanced Individual of the National TCM Monitoring and Statistics Expert Advisory Committee
Outstanding Communist Party Member
Excellence in Teaching & Advanced Educator Awards

With his extensive contributions to TCM policy, research, and education, Sun Qiu’s legacy continues to inspire medical professionals. His future endeavors aim at advancing integrative medicine and fostering global collaboration in TCM research.

🌟 CONCLUSION:

Mr. Qiu Sun is a pioneering force in Traditional Chinese Medicine (TCM), blending innovation with time-honored medical wisdom. His contributions to research, education, and policy-making have significantly shaped the future of integrative medicine. With numerous awards, patents, and publications, he continues to inspire the next generation of TCM professionals. As a leader in clinical excellence and academic advancements, his work plays a vital role in modernizing TCM and expanding its global influence. His dedication ensures that Traditional Chinese Medicine thrives in the 21st century and beyond!

TOP NOTABLE PUBLICATION

The association between serum copper concentration and prevalence of diabetes among US adults with hypertension (NHANES 2011–2016)

Authors: Kaiming Wu, Lixia Chen, Yanyan Kong, Jian-Feng Zhuo, Sun Qiu, Jianfei Chang

Journal: Journal of Cellular and Molecular Medicine

Year: 2024

Yan Zhang | Cardiovascular diseases | Best Researcher Award

Posted on 25/02/202525/02/2025 by Pencis

Prof. Yan Zhang | Cardiovascular diseases | Best Researcher Award

Prof. Yan Zhang, Affiliated Hospital,Liaoning University of Traditional Chinese Medicine, China

Prof. Yan Zhang is a distinguished researcher and medical expert at the Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, China. With extensive experience in Traditional Chinese Medicine (TCM), her research focuses on integrative medicine, herbal formulations, and their clinical applications. She has contributed significantly to the advancement of TCM through numerous publications and collaborative projects. Prof. Zhang is dedicated to bridging modern medical practices with ancient healing traditions, enhancing patient care and treatment efficacy. Her work plays a crucial role in promoting evidence-based TCM approaches for various health conditions, fostering innovation in holistic healthcare solutions.

AUTHOR PROFILE

Scopus Profile

✨ EARLY ACADEMIC PURSUITS:

Prof. Yan Zhang embarked on an illustrious academic journey in Traditional Chinese Medicine (TCM). His foundational education began at Liaoning College of Traditional Chinese Medicine, where he earned a Bachelor’s Degree in Traditional Chinese Medicine (1978-1983). His keen interest in advancing his expertise led him to pursue a Master’s Degree in Typhoid Fever (1986-1989) from the same institution. Determined to further his knowledge, he obtained a Ph.D. in Internal Medicine (2001-2004) from Beijing University of Chinese Medicine, one of China’s most prestigious institutions for TCM studies.

👩‍🎓 PROFESSIONAL ENDEAVORS:

Prof. Zhang’s professional career spans over four decades, marked by dedication and leadership. His significant roles include:

Chief Physician (Since 2012): He has been leading the Cardiopulmonary Department at the Affiliated Hospital of Liaoning University of Traditional Chinese Medicine.
Director of the Department of Research (2006-2012): At the same hospital, he oversaw groundbreaking medical research and contributed to numerous advancements in TCM.
Director of Internal Medicine (1989-2001): He served as the Director of the Department of Traditional Chinese Medicine Internal Medicine at the Liaoning College of Traditional Chinese Medicine Affiliated Hospital.
Early Medical Practice (1983-1986): His career began as a Doctor in the Department of Internal Medicine at Dandong City Traditional Chinese Medicine Hospital.

📚 CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIOVASCULAR DISEASES:

Prof. Zhang is a pioneer in Traditional Chinese Medicine, with a specialized focus on cardiovascular diseases. His research revolves around integrating modern medical techniques with traditional healing practices, making significant strides in the treatment of cardiopulmonary disorders. As an academic leader of China’s national key discipline for cardiovascular research, he has spearheaded numerous studies and projects that have influenced the field profoundly.

He is an expert evaluator for major scientific organizations, including:

China’s National Natural Science Foundation Projects
China’s National Science and Technology Awards

His contributions have been instrumental in shaping national policies and advancements in TCM research.

🌟 IMPACT AND INFLUENCE:

Prof. Zhang’s influence extends beyond his hospital and university. His expertise has earned him several prestigious accolades, including:

Renowned Traditional Chinese Medicine Practitioner of Liaoning Province
Outstanding Talent & Expert of Liaoning Province
Advanced Scientific and Technological Worker in Liaoning Province
Recipient of the Special Allowance of the State Council of China

His mentorship has nurtured numerous doctoral candidates, ensuring that the future of Traditional Chinese Medicine remains in capable hands.

📚 ACADEMIC CITES:

Prof. Zhang’s extensive research and scholarly contributions have been widely cited in various national and international medical journals. His work on cardiovascular health, herbal medicine formulations, and the integration of TCM with modern science has set a benchmark for medical professionals worldwide.

🌟 LEGACY AND FUTURE CONTRIBUTIONS:

Prof. Zhang’s legacy in Traditional Chinese Medicine is monumental. His future contributions aim to:

Develop new treatment methodologies that combine Western and Eastern medical practices.
Mentor the next generation of TCM practitioners.
Influence government health policies for the wider acceptance of TCM in mainstream healthcare.
Continue his groundbreaking research on cardiovascular diseases.

As a visionary leader in Traditional Chinese Medicine, Prof. Yan Zhang’s dedication, research, and teachings will continue to shape the medical landscape for generations to come.

✨CONCLUSION:

Prof. Yan Zhang’s dedication to Traditional Chinese Medicine (TCM) continues to shape the future of integrative healthcare. Through her research, clinical expertise, and innovative approaches, she bridges ancient wisdom with modern medical advancements, ensuring better patient outcomes . Her contributions not only enhance TCM’s credibility worldwide but also inspire future generations of practitioners and researchers. With a passion for holistic healing and evidence-based medicine, Prof. Zhang remains a key figure in promoting natural therapies for global health and wellness. Her work stands as a testament to the enduring power of TCM in modern medicine.

TOP NOTABLE PUBLICATION

Mechanism of Ferroptosis in Regulating Chronic Heart Failure and Traditional Chinese Medicine Prevention and Treatment Based on Qi Deficiency and Stagnation: A Review

Authors: Z., Yuan, Ziyang, Y., Zhang, Yan, W., Zhang, Wei, … G., Yang, Guo, X., Wang, Xuewei

Journal: Chinese Journal of Experimental Traditional Medical Formulae

Year: 2025

Atsuko Nakayama | Cardiac Rehabilitation | Best Researcher Award

Posted on 17/02/202517/02/2025 by Pencis

Dr. Atsuko Nakayama | Cardiac Rehabilitation | Best Researcher Award

Dr. Atsuko Nakayama, Sakakibara Heart Institute, Japan

Dr. Atsuko Nakayama, M.D., Ph.D., is a renowned cardiologist and expert in cardiovascular medicine and rehabilitation at the Sakakibara Memorial Hospital in Japan. She serves as the Director of the Department of Cardiovascular Medicine, Head of the Cardiac Rehabilitation Unit, and Director of the Comprehensive Support Center for Heart Disease. Dr. Nakayama is a pioneer in integrating AI and telemedicine into cardiac care and rehabilitation, with a focus on personalized treatment plans and wearable technologies. She holds leadership roles in several professional organizations and contributes to national policies on cardiovascular disease as a member of Japan’s Ministry of Health, Labour, and Welfare.

AUTHOR PROFILE

Scopus Profile

Orcid Profile

🎓EARLY ACADEMIC PURSUITS:

Dr. Atsuko Nakayama’s academic journey began with a strong foundation in medicine, culminating in a Doctorate from the prestigious University of Tokyo in March 2012. Her passion for cardiovascular medicine was evident from early on, and her academic excellence set the stage for a career that would merge clinical practice with cutting-edge research. Her early studies laid the groundwork for her future focus on medical device development, telemedicine, and rehabilitation in the cardiovascular field.

🏥PROFESSIONAL ENDEAVORS:

Dr. Nakayama currently holds multiple leadership roles at the Sakakibara Memorial Hospital, where she serves as the Director of the Department of Cardiovascular Medicine, Head of the Cardiac Rehabilitation Unit, and Director of the Comprehensive Support Center for Heart Disease. Her leadership extends beyond her hospital, as she has been appointed as the representative of the Heart Disease Work-Life Balance Support Network in December 2024. Additionally, since June 2024, Dr. Nakayama has been a member of the Cardiovascular Disease Control Promotion Council under Japan’s Ministry of Health, Labour, and Welfare.

Her professional endeavors reflect a commitment to both the clinical and policy aspects of cardiovascular health. She has been at the forefront of integrating new technologies and rehabilitation approaches into routine care, improving patient outcomes through innovation.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIAC REHABILITATION:

Dr. Nakayama’s research has focused on advancing the integration of technology in cardiovascular medicine, particularly through the use of artificial intelligence (AI) and telemedicine. She is recognized for her work in developing AI-driven diagnostic tools, wearable technologies, and remote cardiac rehabilitation programs. Her research also spans exercise physiology, aortic aneurysms, hypertrophic cardiomyopathy, and healthcare quality assessment.

Her pioneering work has enabled the development of AI-assisted patient monitoring systems and personalized treatment plans, revolutionizing cardiac rehabilitation. Dr. Nakayama has been instrumental in incorporating AI and big data analytics into cardiovascular care, allowing for predictive and preventive interventions in heart disease.

🌍IMPACT AND INFLUENCE:

Dr. Nakayama’s contributions extend well beyond the hospital and laboratory. Through her leadership in various professional organizations, including serving as the chair of the JCS-JJC committee of the Japanese Circulation Society since 2022, she has influenced the direction of cardiovascular research and practice in Japan. Her role in national policy-making, including her position on the Cardiovascular Disease Control Promotion Council, allows her to shape public health initiatives and promote AI-powered healthcare solutions on a national scale.

Her influence has been recognized by prestigious awards, including the “STI for SDGs” Award from the Japan Science and Technology Agency in 2024, recognizing her groundbreaking work in remotecardiac rehabilitation

📚ACADEMIC CITATIONS:

Dr. Nakayama’s research has been widely cited in the fields of telemedicine, AI in healthcare, and cardiovascular rehabilitation. Her work has paved the way for numerous studies exploring the use of technology to improve patient outcomes. As a fellow of both the Japanese Circulation Society and the American Heart Association, her research continues to have a significant impact on the scientific community.

🔮LEGACY AND FUTURE CONTRIBUTIONS:

Dr. Nakayama’s legacy is one of innovation, leadership, and compassionate care. Her contributions to AI-driven healthcare, particularly in the field of cardiology, have set new standards in patient care and rehabilitation. As she continues her work in AI-assisted diagnostics and rehabilitation, her future contributions promise to further revolutionize cardiovascular medicine and improve the lives of millions of patients.

Her ongoing efforts to shape policies, integrate cutting-edge technologies into clinical practice, and advocate for better healthcare systems ensure that Dr. Nakayama’s impact will be felt for years to come, leaving a lasting legacy in the world of medicine.

🌟CONCLUSION:

Dr. Atsuko Nakayama is a trailblazer in the field of cardiovascular medicine, combining clinical expertise with groundbreaking research in AI and telemedicine. Her leadership at Sakakibara Memorial Hospital, coupled with her contributions to national health policies, has made a lasting impact on cardiac care and rehabilitation in Japan. Through her innovative use of technology, she continues to improve patient outcomes and shape the future of healthcare. Dr. Nakayama’s dedication to advancing both medicine and healthcare systems ensures that her work will inspire generations of clinicians and researchers.

TOP NOTABLE PUBLICATIONS:

A national survey of career development according to gender and subspecialties among cardiologists in Japan
Authors: M. Shimbo, A. Nakayama, N. Fukue, T. Taniguchi, Y. Kobayashi
Journal: PLoS ONE
Year: 2025

Predicting Heart Rate at the Anaerobic Threshold Using a Machine Learning Model Based on a Large-Scale Population Dataset
Authors: A. Nakayama, T. Iwata, H. Sakuma, K. Kashino, H. Tomoike
Journal: Journal of Clinical Medicine
Year: 2025

Impact of Long-Term Exercise-Based Cardiac Rehabilitation in Patients With Chronic Heart Failure ― A Systematic Review and Meta-Analysis
Authors: S. Yamamoto, M. Okamura, Y. Akashi, S. Makita, M. Isobe
Journal: Circulation Journal
Year: 2024
Citations: 2

Sex Differences in Cardiovascular Disease-Related Hospitalization and Mortality in Japan ― Analysis of Health Records From a Nationwide Claim-Based Database, the Japanese Registry of All Cardiac and Vascular Disease (JROAD)
Authors: S. Noma, K. Kato, T. Otsuka, K. Maemura, Y.T. Tsukada
Journal: Circulation Journal
Year: 2024

Lingyan Chen | Cardiovascular Diseases | Best Researcher Award

Posted on 17/02/202517/02/2025 by Pencis

Dr. Lingyan Chen | Cardiovascular Diseases | Best Researcher Award

Dr. Lingyan Chen, Wenzhou Medical university, China

Dr. Lingyan Chen is an Associate Researcher at Wenzhou Medical University, China, specializing in mitochondrial quality control and disease pathogenesis. She holds a Ph.D. from Wenzhou Medical University (2019-2022) and completed a postdoctoral fellowship at Guangzhou Medical University (2019-2024). Her research focuses on gene knockout models, tumor studies, and cardiovascular pharmacology. She has received multiple awards, including honors from the Circulation Journal Awards (Japan) and the Zhejiang Society of Biochemistry. With extensive experience in molecular biology techniques, Dr. Chen continues to advance biomedical research, aiming to develop novel therapeutic strategies for metabolic and cardiovascular diseases.

AUTHOR PROFILE

Scopus Profile

🎓EARLY ACADEMIC PURSUITS:

Dr. Lingyan Chen embarked on her academic journey at Changsha Medical University, earning a B.Sc. degree (2006-2009). She then pursued a M.Sc. at The University of South China (USC) (2015-2018), where she focused on pathogenesis and prevention of atherosclerosis, supported by prestigious research grants. She completed her Ph.D. at Wenzhou Medical University (WMU) (2019-2022), concentrating on mitochondrial quality control and its implications for related diseases.

🏥PROFESSIONAL ENDEAVORS:

🔹 Guangzhou Medical University (Postdoctoral Researcher) (2019-2024) – Advanced research in mitochondrial pathogenesis and disease modeling.
🔹 Guangzhou Medical School (Assistant Professor) (2018) – Engaged in pharmacology research on cardiovascular diseases.
🔹 Guangzhou Medical University (Research Assistant) (2018) – Coordinated multi-institutional research projects and managed key laboratory operations.
🔹 The Second People’s Hospital of Changde (Pediatric Nurse) (2009-2015) – Provided clinical care for newborns and critically ill children, mentoring trainee nurses.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIOVASCULAR DISEASES:

Dr. Chen’s research spans multiple domains in biomedical sciences, including:
✅ Mitochondrial Quality Control & Disease Mechanisms – Investigated gene knockout/knockin mice models, heterogeneous tumors, and disease modeling for liver cancer and diabetes.
✅ Cardiovascular Pharmacology – Conducted Western Blotting, qPCR, immunofluorescence, and genetic experiments on macrophage behavior.
✅ Atherosclerosis & Hypertriglyceridemia – Studied clinical patient data, serum sample analysis, and statistical evaluations to uncover disease mechanisms.

🌍IMPACT AND INFLUENCE:

Dr. Chen has significantly influenced mitochondrial pathogenesis and cardiovascular research, contributing valuable insights into gene expression, disease prevention, and targeted treatments. Her research findings have aided in therapeutic advancements, particularly in cardiovascular disorders and metabolic diseases.

📚ACADEMIC CITES & LEGACY:

Dr. Chen’s research has been published in top-tier scientific journals, earning citations in the fields of biochemistry, molecular biology, and cardiovascular medicine. Her work serves as a foundation for future studies in mitochondrial dysfunction and therapeutic innovations.

🚀FUTURE CONTRIBUTIONS & VISION:

As an Associate Researcher at Wenzhou Medical University (2025-Present), Dr. Chen continues her groundbreaking research in mitochondrial medicine and disease pathogenesis. She aims to:
🔹 Develop novel therapeutic strategies for cardiovascular and metabolic disorders.
🔹 Expand research on genetic and molecular mechanisms underlying disease progression.
🔹 Mentor the next generation of biomedical researchers and medical professionals.

🏆AWARDS AND HONORS:

🔹 2020 – Second Prize in the 16th Graduate Academic Competition, Wenzhou Medical University
🔹 2020 – Second Prize in the “Xinzhi” Youth Forum, Zhejiang Society of Biochemistry and Molecular Biology
🔹 2018 – Second Prize for Excellent Experimental Research Paper, Circulation Journal Awards (Japan)
🔹 2018 – Outstanding Communist of the University of South China
🔹 2017 – 3rd Prize, Young Investigator Oral Presentation, 14th National Conference on Atherosclerotic Diseases & China-Canada Symposium
🔹 2017 – Excellence Award, Young Investigator Oral Presentation, Cross-Strait Cardiovascular Science Symposium
🔹 2017 – 1st Scholarship, University of South China
🔹 2016 – 2nd Scholarship, University of South China
🔹 2015 – 2nd Scholarship, University of South China

🌟CONCLUSION:

Dr. Lingyan Chen’s dedication to biomedical research, particularly in mitochondrial quality control and cardiovascular pharmacology, has significantly contributed to understanding disease mechanisms and potential treatments. Her extensive experience in molecular biology, combined with numerous accolades and publications, underscores her impact in the scientific community. As she continues her research at Wenzhou Medical University, Dr. Chen remains committed to advancing medical science, mentoring future researchers, and developing innovative therapeutic strategies. Her work holds great promise for improving treatments for metabolic and cardiovascular diseases, making her a valuable figure in the field of biomedical research.

TOP NOTABLE PUBLICATIONS

Inhibition of mitochondrial OMA1 ameliorates osteosarcoma tumorigenesis

Authors: Chen, Lingyan; Chen, Dejian; Pan, Yiming; Zhang, Dawei; Xia, Xiaodan

Journal: Cell Death and Disease

Year: 2024

Ciclopirox drives growth arrest and autophagic cell death through STAT3 in gastric cancer cells

Authors: Chen, Lingyan; Chen, Dejian; Li, Jiwei; Lu, Xiaoang; Lu, Bin

Journal: Cell Death and Disease

Year: 2022

MicroRNA-377 inhibits atherosclerosis by regulating triglyceride metabolism through the DNA methyltransferase 1 in apolipoprotein E-knockout mice

Authors: Chen, Lingyan (First Author); Xia, Xiaodan; Zhao, Zhiwei; Gong, Dan; Ma, Xuefeng; Yu, Xuhui; Zhang, Qi; Wang, Shengqi; Dai, Xinyu; Zheng, Xianliang; Zhang, Dawei; Yin, Wende; Tang, ChaoKun

Journal: Circulation Journal

Year: 2018

Myocardin suppression increases lipid retention and atherosclerosis via downregulation of ABCA1 in vascular smooth muscle cells

Authors: Xia, Xiaodan; Yu, Xuhui; Chen, Lingyan (Co-first Author); Xie, Shuo; Feng, Yan; Yang, Rui; Zhao, Zhiwei; Li, Hui; Wang, Gang; Tang, ChaoKun

Journal: Biochimica et Biophysica Acta (BBA) – Molecular and Cell Biology of Lipids

Year: 2021

Heart shock protein 70 accelerates atherosclerosis by downregulating the expression of ABCA1 and ABCG1 through the JNK/Elk-1 pathway

Authors: Zhao, Zhiwei; Zhang, Min; Chen, Lingyan (Co-first Author); Gong, Dan; Xia, Xiaodan; Yu, Xuhui; Wang, Shengqi; Ou, Xue; Dai, Xinyu; Zheng, Xianliang; Zhang, Dawei; Tang, ChaoKun

Journal: Biochimica et Biophysica Acta

Year: 2018

Puerarin promotes ABCA1-mediated cholesterol efflux and decreases cellular lipid accumulation in THP-1 macrophages

Authors: Li, ChaoHui; Gong, Dan; Chen, Lingyan (Co-first Author); Zhang, Min; Xia, Xiaodan; Cheng, Hongping; Huang, Chen; Zhao, Zhiwei; Zheng, Xianliang; Tang, XueEr; Tang, ChaoKun

Journal: European Journal of Pharmacology

Year: 2017

IL-8 negatively regulates ABCA1 expression and cholesterol efflux via upregulating miR-183 in THP-1 macrophage-derived foam cells

Authors: Tang, XueEr; Li, Hui; Chen, Lingyan (Co-first Author); Xia, Xiaodan; Zhao, Zhiwei; Zheng, Xianliang; Zhao, GuoJun; Tang, ChaoKun

Journal: Cytokine

Year: 2019

Eliza Wong | Cardiac Nursing | Best Researcher Award

Posted on 22/01/202524/01/2025 by Pencis

Dr. Eliza Wong | Cardiac Nursing | Best Researcher Award

Dr. Eliza Wong, Tung Wah College, Hong Kong

Dr. Eliza Wong is an esteemed Associate Professor at Tung Wah College, Hong Kong, with extensive experience in nursing education, research, and clinical practice. She specializes in e-health interventions, acute care, and cardiovascular nursing, focusing on preventive care, gerontechnology, and lifestyle educational programs. Dr. Wong’s impactful research has garnered substantial funding, including Health and Medical Research Fund (HMRF) grants, and her work is widely published in leading international journals. A dedicated mentor and global collaborator, she actively advances nursing education and practice, shaping the next generation of healthcare professionals and contributing to improved patient outcomes worldwide.

Author Profile

Scopus Profile

Orcid Profile

Google Scholar Profile

EDUCATION:

Dr. Wong Mi Ling, Eliza, possesses an impressive academic foundation in nursing and healthcare management. She earned her PhD in Nursing from The Chinese University of Hong Kong (2003–2009), focusing on improving patient care through evidence-based research. She also holds a Master of Nursing from Deakin University, Australia (1999–2001), and a Master of Health Administration from the University of New South Wales, Australia (1995–1997), which reflect her dual expertise in clinical practice and healthcare leadership. Additionally, she completed her Bachelor of Health Science in Nursing at the University of Western Sydney, Australia (1992–1993), establishing her strong clinical foundation.

PROFESSIONAL QUALIFICATION:

Dr. Wong Mi Ling, Eliza, boasts outstanding professional qualifications in nursing and healthcare. She is a Fellow of the Hong Kong College of Education and Research at the Hong Kong Academy of Nursing (HKAN) since 2012 . A committed member of Sigma (Pi Lota at-Large Chapter) , she has been a Registered General Nurse in Hong Kong since 1982 and a Registered Midwife since 1984 . Her international credentials include being a Registered Nurse in NSW, Australia (1990–2017). Additionally, she has certifications in International Trauma Life Support (2017–2021) and Basic Life Support (2017–2019) .

PROFESSIONAL EXPERIENCE:

Dr. Wong Mi Ling, Eliza, has an extensive professional journey in nursing and education. She serves as an Associate Professor at Tung Wah College (2021–present) and previously held roles at the Polytechnic University of Hong Kong as Principal Research Fellow (2020–2021) and Assistant Professor (2017–2020) . She has also contributed as a Nurse Educator at Hong Kong Sanatorium & Hospital (2016–2017) and Assistant Professor at CUHK (2010–2016) . Her diverse experience spans roles in nursing education, consultancy, and frontline care in Hong Kong and Australia, including A&E, obstetrics, and rehabilitation units .

RESEARCH INTERESTS ON CARDIAC NURSING:

Dr. Wong Mi Ling, Eliza, research interests encompass e-health interventions for conditions like coronary heart disease and metabolic syndrome, acute care with a focus on pain and emergency nursing, and cardiovascular nursing, including preventive care, rehabilitation, and lifestyle education. Their PhD research emphasized educational interventions in acute pain management for patients with limb fractures. With extensive experience in emergency nursing, their studies explore nurse-led wound care and triage pain management. Since 2017, they have focused on gerontechnology and health literacy for older adults, securing significant grants. Their prolific contributions include 46 international publications, numerous impactful conference papers, and active roles in collaborative research and peer review.

AWARDS AND HONORS:

Dr. Wong Mi Ling, Eliza has received numerous awards and honors throughout her distinguished career. Her accolades reflect her outstanding contributions to nursing education, research, and practice. Dr. Wong has been recognized for her impactful work in cardiovascular nursing and e-health interventions, securing prestigious research grants such as the Health and Medical Research Fund (HMRF) and Knowledge Transfer Fund. She serves as a member of the International Advisory Board for International Emergency Nursing and actively contributes as a peer reviewer for esteemed journals like BMJ Open Access and the Journal of Advanced Nursing. Her dedication continues to inspire excellence in nursing.

CITATIONS:

Citations – 2074
h-index – 26
i10-index – 58

CONCLUSION:

Dr. Wong Mi Ling, Eliza has established herself as a visionary leader in nursing, blending rich clinical experience with groundbreaking research and education. Her contributions to e-health interventions, acute care, and cardiovascular nursing have significantly advanced nursing practice and patient care. Through her commitment to mentorship, she has nurtured the next generation of healthcare professionals, fostering innovation and academic excellence. With a global reputation as a scholar, advisor, and educator, Dr. Wong continues to drive progress in nursing, ensuring her work has a lasting impact on healthcare systems and communities worldwide. Her dedication remains a beacon of inspiration and excellence.

TOP NOTABLE PUBLICATIONS

Title: The associations of e-health perception and dementia knowledge with dementia public stigma in nursing students: A cross-sectional study
Authors: Su, J.J., Tsui, K.Y., Lam, S.C., Suen, L.K.P., Kwan, R.Y.C.
Journal: Nurse Education Today
Year: 2025, 146, 106532

Title: Effect of a Nurse-Led Support Program Using Mobile Application Versus Nurse Phone Advice on Patients at Risk of Coronary Artery Disease: A Randomized Controlled Trial
Authors: Wong, E.M.L., Leung, D.Y.P., Lam, S.C., Ko, S.Y., Leung, A.Y.M.
Journal: Worldviews on Evidence-Based Nursing
Year: 2025, 22(1), e12765

Title: Lifestyle intervention using a mobile application versus booklet for adults with metabolic syndrome: a multicentre randomised controlled trial (abridged secondary publication)
Authors: Leung, D.Y.P., Wong, E.M.L., Leung, A.M.Y., Cheung, A.S.P., Cheung, K.C.
Journal: Hong Kong Medical Journal
Year: 2024, 30(6), pp. 12–16

Title: Coping strategies of internally displaced persons and the host community in a region of armed conflict: A cross-sectional study
Authors: Salihu, D., Chutiyami, M., Bello, U.M., Sulaiman, S.K., Kwan, R.Y.C.
Journal: Psychiatry Research
Year: 2024, 339, 116035

Title: Effectiveness of a home-based music-paced physical activity programme on exercise-related outcomes after cardiac rehabilitation: a randomized controlled trial
Authors: Chair, S.Y., Cheng, H.Y., Lo, S.W.S., Choi, K.C., Leung, T.S.Y.
Journal: European Journal of Cardiovascular Nursing
Year: 2024, 23(5), pp. 510–520

Title: Integrated Health Education Programmes With Physical Activity Among Community-Dwelling Older Adults at Risk of Atherosclerotic Cardiovascular Disease: An Integrative Review of Experimental Studies
Authors: Lo, F., Wong, E., Lam, K., Huang, X., Ho, K.
Journal: Journal of Advanced Nursing
Year: 2024

Title: Effects of virtual reality on anxiety and pain in adult patients undergoing wound-closure procedures: A pilot randomized controlled trial
Authors: Ko, S.Y., Wong, E.M.L., Ngan, T.L., Tam, H.F., Chan, C.C.
Journal: Digital Health
Year: 2024, 10

Title: Music-paced physical activity intervention for patients with coronary heart disease: abridged secondary publication
Authors: Chair, S.Y., Sit, J.W.H., Wong, E.M.L., Yu, D.S.F., Leung, T.S.Y.
Journal: Hong Kong Medical Journal
Year: 2024, 30(1), pp. 18–22

Title: Sensitivity and specificity of conventional and new face validation in determining the incomprehensible items by older people: Empirical evidence of testing 106 quality-of-life items
Authors: Lam, S.C., Suen, L.K.P., Huang, E.Y.-Z., Cheung, D.S.K., Kwan, R.Y.C.
Journal: Aging Medicine
Year: 2023, 6(3), pp. 230–238

Title: The effect of a lifestyle intervention program using a mobile application versus the effect of a program using a booklet for adults with metabolic syndrome: A three-arm randomized controlled trial
Authors: Wong, E.M.L., Leung, D.Y.P., Wang, Q., Leung, A.Y.M., Cheung, A.S.P.
Journal: Journal of Nursing Scholarship
Year: 2023, 55(5), pp. 936–948

Fulin Liu | Cardiology | Best Researcher Award

Posted on 12/12/202412/12/2024 by Pencis

Prof. Fulin Liu | Cardiology | Best Researcher Award

Prof. Fulin Liu, Affiliated Hospital of Hebei University , China

Prof. Fulin Liu is a distinguished researcher and cardiac surgeon affiliated with the Affiliated Hospital of Hebei University, where he has worked since 1988. He holds a degree from Hebei Medical University and has made significant contributions to cardiovascular health, particularly in myocardial ischemia-reperfusion injury and the therapeutic effects of hydrogen-rich water. Liu has authored numerous high-impact journal articles, with recent work focusing on mitochondrial function, glioma research, and innovative healthcare solutions. His research is widely recognized in leading medical journals, underscoring his global impact and ongoing commitment to advancing medical science and patient care.

Author Profile:

Education:

Prof. Fulin Liu completed his undergraduate education at Hebei Medical University in Shijiazhuang City, Hebei, China. He attended the university from September 1983 to June 1988, where he received a medical degree, which laid the foundation for his career in cardiac surgery and medical research. This academic background has been pivotal in shaping his research focus, particularly in the fields of cardiovascular health, ischemia-reperfusion injury, and the application of hydrogen-rich water in medical treatments. Liu’s educational experiences at Hebei Medical University have significantly influenced his innovative contributions to healthcare and medical science.

Professional Experience:

Prof. Fulin Liu has extensive professional experience in both clinical and research settings. Since 1988, he has been a cardiac surgeon at the Affiliated Hospital of Hebei University, where he has developed expertise in treating cardiovascular conditions, particularly myocardial ischemia-reperfusion injury. In addition to his clinical role, Liu has made significant contributions to medical research, publishing numerous articles on topics such as hydrogen-rich water, mitochondrial function, and glioma. His work bridges the gap between clinical practice and scientific discovery, advancing both patient care and medical knowledge. Liu’s career reflects a dedicated commitment to improving cardiovascular health and innovative therapies.

🌍Research Contributions:

Prof. Fulin Liu’s research contributions focus primarily on cardiovascular health, particularly myocardial ischemia-reperfusion injury and the protective effects of hydrogen-rich water. His studies have revealed critical insights into mitochondrial function and its role in heart disease, with a focus on improving therapeutic strategies. Liu has also made notable contributions to the understanding of gliomas, including the role of circular RNAs and N6-methyladenosine modifications in tumor progression. His work extends to advanced healthcare technologies, such as knowledge graphs and mobile computing in medical applications. Through his numerous published articles, Liu continues to drive innovative research with significant clinical and therapeutic implications.

Award and Honors:

Prof. Fulin Liu has received numerous awards and honors throughout his distinguished career, recognizing his contributions to the field of cardiac surgery and medical research. His groundbreaking work on myocardial ischemia-reperfusion injury, hydrogen-rich water’s therapeutic effects, and his studies on gliomas have earned him widespread acclaim in the scientific community. Liu’s research has been published in top-tier medical journals, and his expertise has garnered international recognition. His dedication to advancing both clinical practices and scientific understanding has established him as a leader in his field, earning him significant accolades and reinforcing his reputation as a pioneering researcher.

Conclusion:

Prof. Fulin Liu’s extensive research and clinical expertise have made him a prominent figure in the field of cardiac surgery and biomedical research. His work on myocardial ischemia-reperfusion injury, hydrogen-rich water, and its therapeutic potential highlights his commitment to advancing cardiovascular medicine. Liu’s contributions to the understanding of molecular mechanisms in diseases like glioma further underscore his multidisciplinary approach to health research. With a remarkable publication record and ongoing involvement in clinical practice, Liu’s impact on both academic and medical communities is profound, establishing him as a leading figure in his field.

Publication Top Notes:

Hydrogen Protects Mitochondrial Function by Increasing the Expression of PGC-1α and Ameliorating Myocardial Ischaemia–Reperfusion Injury
Journal of Cellular and Molecular Medicine, 2024
📖 Citations: 0
[DOI: 10.1111/jcmm.70236]

Spatiotemporal lipidomics reveals key features of brain lipid dynamic changes after cerebral ischemia and reperfusion therapy
Pharmacological Research, 2022
🧠 Citations: 15
[DOI: 10.1016/j.phrs.2022.106482]

Identification and characterization of N6-methyladenosine modification of circRNAs in glioblastoma
Journal of Cellular and Molecular Medicine, 2021
🔬 Citations: 8
[DOI: 10.1111/jcmm.16750]

Multitask Healthcare Management Recommendation System Leveraging Knowledge Graph
Journal of Healthcare Engineering, 2021
💡 Citations: 19
[DOI: 10.1155/2021/1233483]

Medical Knowledge Graph in Chinese Using Deep Semantic Mobile Computation Based on IoT and WoT
Wireless Communications and Mobile Computing, 2021
🌐 Citations: 6
[DOI: 10.1155/2021/5590754]

M6A modification in RNA: Biogenesis, functions and roles in gliomas
Journal of Experimental and Clinical Cancer Research, 2020
🧬 Citations: 117
[DOI: 10.1186/s13046-020-01706-8]

Metabolomics Analysis of the Effect of Hydrogen-Rich Water on Myocardial Ischemia-Reperfusion Injury in Rats
Journal of Bioenergetics and Biomembranes, 2020
💧 Citations: 6
[DOI: 10.1007/s10863-020-09835-7]

Advances in circular RNAs and their role in glioma (Review)
International Journal of Oncology, 2020
🔄 Citations: 26
[DOI: 10.3892/ijo.2020.5049]

New understanding of the damage of SARS-CoV-2 infection outside the respiratory system
Biomedicine and Pharmacotherapy, 2020
🦠 Citations: 222
[DOI: 10.1016/j.biopha.2020.110195]

Pressurizing and Stretching Experiment in Arterialized Veins of Rabbits
Yiyong Shengwu Lixue/Journal of Medical Biomechanics, 2020
🐇 Citations: Not available
[DOI: 10.3969/j.issn.1005-8936.2020.02.006]

Paweł Rajewski | Cardiovascular risk | Best Research Article Award | Best Research Article Award

Posted on 11/11/202411/11/2024 by Pencis

Prof Dr. Paweł Rajewski | Cardiovascular risk | Best Research Article Award

Prof Dr. Paweł Rajewski, WSOZ, Poland

🌟Bioinformatics:

Prof. Dr. Paweł Rajewski is a leading expert in internal medicine, infectious diseases, hepatology, and clinical transplantation. Serving as the Rector of the Faculty of Health Sciences at the University of Health Sciences in Bydgoszcz, Poland, he is also the Provincial Consultant in Infectious Diseases for the Kuyavian-Pomeranian Voivodeship. In addition, he heads both the Department of Internal Medicine and Infectious Diseases at Tadeusz Browicz Provincial Infectious Disease Hospital and the Liver, Internal, Infectious, and Metabolic Disorders Clinic at CM Gizińscy in Bydgoszcz. Dr. Rajewski is a certified lipidologist and obesitologist, with over 200 published articles focusing on metabolic disorders, liver diseases, and cardiovascular health. He is also the founder of the Dr. Rajewski Foundation, which supports research and education in health sciences.

Profile:

Orcid Profile

🏥Current Position and Roles:

Dr. Paweł Rajewski is a distinguished medical doctor, professor, and the rector of the Faculty of Health Sciences at the University of Health Sciences in Bydgoszcz. He holds the vital role of Provincial Consultant in Infectious Diseases for the Kuyavian-Pomeranian Voivodeship, providing oversight and strategic insights on infectious disease management in the region. Dr. Rajewski serves as the Head of the Department of Internal Medicine and Infectious Diseases at the Tadeusz Browicz Provincial Infectious Disease Hospital in Bydgoszcz, as well as the Head of the Liver, Internal, Infectious, and Metabolic Disorders Clinic at CM Gizińscy in Bydgoszcz. Previously, he served as the Medical Director and Head of the Department of Internal Medicine and Hepatology at the Emil Warmiński Multispecialist City Hospital. Through these roles, he contributes to the health of countless patients while also shaping medical policy and practice.

🎓Academic Background:

Dr. Rajewski’s academic journey has been marked by an enduring commitment to medicine, specializing in areas such as internal medicine, infectious diseases, hepatology, and clinical transplantation. His qualifications in these areas form the bedrock of his clinical and academic expertise, enabling him to deliver high-impact research and patient care in fields that are central to public health. Dr. Rajewski’s education includes specialty certifications as a lipidologist, accredited by the Polish Lipid Association, and an obesitologist with certifications from the Polish Association for the Study of Obesity and the Polish Society for Obesity Treatment.

📚Research Interests and Publication Achievements:

Dr. Rajewski has contributed over 200 articles, primarily focused on metabolic disorders, obesity, liver diseases, and cardiovascular risk factors. His work, published in reputed medical journals, has been instrumental in advancing knowledge on these critical health issues. His research sheds light on complex metabolic processes, influencing both preventive and therapeutic approaches to conditions like non-alcoholic fatty liver disease and atherosclerosis. His publications are widely recognized for their scientific rigor and relevance, contributing to his esteemed reputation in the medical research community.

🔬Ongoing Research Projects:

Dr. Rajewski is currently engaged in various research projects that address emerging concerns in metabolic health and infectious diseases. His work on liver disease mechanisms and cardiovascular risk factors associated with obesity and metabolic syndrome aims to uncover better diagnostic markers and treatment pathways. A recent focus involves studying COVID-19’s impact on liver function and the interplay between viral infections and metabolic health, topics highly relevant in today’s healthcare landscape.

👥Professional Associations and Certifications:

Dr. Rajewski’s memberships in prestigious medical associations, including the Polish Lipid Association and the Polish Association for the Study of Obesity, underscore his dedication to staying at the forefront of medical science. His certified expertise as a lipidologist and obesitologist enables him to approach health issues with a comprehensive understanding of lipid and metabolic disorders, enhancing the efficacy of treatments and preventive measures.

🏆Scholarships and Awards:

Dr. Rajewski’s contributions to medicine have earned him numerous accolades, recognizing his achievements in research and clinical practice. These awards celebrate his innovation in metabolic research and his pivotal role in infectious disease management. His scholarship funding reflects a legacy of excellence and a commitment to advancing medical science.

📖Training & Workshops Attended:

In his pursuit of continual growth, Dr. Rajewski has attended a series of specialized workshops on bioinformatics, advanced diagnostics, and clinical applications in infectious disease management. These workshops equip him with cutting-edge skills that he applies to his daily work, benefiting patients and enhancing the training of his medical students.

💻Contributions to Bioinformatics and Clinical Research:

A proficient bioinformatician, Dr. Rajewski integrates data science and computational tools in his research on metabolic diseases and infectious pathogens. By utilizing bioinformatics, he has been able to analyze complex datasets, leading to insights into genetic predispositions and disease progression. His ability to harness bioinformatics tools strengthens his work in both metabolic and infectious disease studies, positioning him at the cutting edge of medical research.

🎤Oral Presentations and Conferences:

As a frequent presenter at national and international conferences, Dr. Rajewski shares his research findings with the medical community. His presentations cover topics like liver disease pathogenesis, metabolic syndrome treatments, and emerging infectious diseases. He contributes actively to knowledge exchange, with his lectures serving as valuable learning resources for both peers and students.

📊Key Tasks and Responsibilities as a Researcher:

In his research role, Dr. Rajewski coordinates multi-disciplinary teams, designing studies, and conducting extensive data analyses. His responsibilities include overseeing clinical trials and ensuring the ethical integrity of research protocols. His dedication to stringent research standards has led to significant findings that improve patient care protocols and inform public health strategies.

🌠Success Factors:

Dr. Rajewski attributes his success to his commitment to continuous learning, innovation, and collaboration. His ability to bridge theoretical research with practical applications in healthcare makes his contributions exceptionally valuable. Additionally, his leadership in the clinical setting exemplifies his holistic approach to healthcare, balancing research with direct patient care.

🔍Publications & Laboratory Experience:

Dr. Rajewski’s extensive laboratory experience includes advanced diagnostics in liver diseases, where he employs innovative techniques to diagnose and manage conditions like hepatitis and liver fibrosis. His publications detail his findings on the effectiveness of new biomarkers, offering insights that enhance both diagnostics and treatment options for liver and metabolic disorders.

🌐Conclusion:

Dr. Paweł Rajewski’s career exemplifies a dedication to excellence in medicine, research, and public health. His multifaceted expertise in internal medicine, infectious diseases, and metabolic health has propelled him to the forefront of healthcare in Poland. Dr. Rajewski’s contributions are invaluable to the fields of hepatology and infectious disease, positively impacting patient care and advancing medical knowledge. Through his foundation, research, and clinical roles, he continues to shape the future of health sciences, creating a lasting legacy of compassion, knowledge, and innovation.

Top Notable Publications:

Hepatitis C Infection Is Not a Cardiovascular Risk Factor in Young Adults